Medical

The International Primary Care Respiratory Group (IPCRG) has launched a petition in support of its Fresh Air Uganda study in response to what it says is a growing threat in the region, with COPD expected… Read more . . .

Massachusetts biotech company Pulmatrix presented data from two studies of its Pulmatrix presents data from preclinical studies of its lead product, PUR118, an inhaled cationic airway lining modulator (iCALM) for the treatment of respiratory diseases… Read more . . .

Almirall has presented a number of posters at the 2011 Annual Congress of the European Respiratory Society (ERS), including, for the first time, full data from the six-month Phase 3 ATTAIN study of its aclidinium… Read more . . .

MicroDose Therapeutx has initiated a Phase 1 clinical trial of MDT-637, an inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus (RSV) that is delivered using the company’s novel dry powder… Read more . . .

Two posters presented by Pearl Therapeutics at the 2011 European Respiratory Society meeting show additional data from a Phase 2b study demonstrating that Pearl’s glycopyrrolate (GP)/fomoterol fumarate (FF) fixed combination metered dose inhaler and its… Read more . . .

According to Mundipharma, three Phase 3 studies of the Flutiform fluticasone propionate/formoterol fumarate metered dose inhaler (MDI) have demonstrated that the product “had comparable efficacy in improving the lung function and a similar safety profile… Read more . . .

Elevation Pharmaceuticals has presented positive results from a Phase 2a study of its glycopyrrolate inhalation solution in patients with moderate to severe COPD at the European Respiratory Society (ERS) meeting in Amsterdam. If Elevation can… Read more . . .

The European Lung Foundation has launched a website for its AirPROM consortium, a group formed “to integrate and enhance the capacities of all partners to deliver the best possible outcome for people with asthma and… Read more . . .

The Congress of Delegates of the American Academy of Family Physicians (AAFP) has approved a resolution calling for the organization “to work with public and private payers to ensure the lowest copays for at least… Read more . . .